Hospice News September 27, 2024
Contessa, the innovation and high-acuity arm of Amedisys Inc. (NASDAQ: AMED) has made large investments in expanding access to palliative care, particularly through joint ventures with health systems.
Amedisys acquired Contessa in 2021 for $250 million. The subsidiary’s specialty is high-acuity care in the home, including hospital-at-home and skilled nursing facility-at-home programs, but in recent years it has also leaned hard into growing its palliative care business.
For now, Amedisys shows no signs of slowing down on palliative care. Expanding palliative care relationships and joint venture partnerships is a priority for 2024, the Louisiana-based home health and hospice provider indicated in a filing with the U.S. Securities and Exchange Commission (SEC) earlier this year.
“Our expertise and capabilities in these...
Today's Sponsors
Today's Sponsor